131 related articles for article (PubMed ID: 11121536)
21. Ezrin immunoreactivity is associated with increasing malignancy of astrocytic tumors but is absent in oligodendrogliomas.
Geiger KD; Stoldt P; Schlote W; Derouiche A
Am J Pathol; 2000 Dec; 157(6):1785-93. PubMed ID: 11106550
[TBL] [Abstract][Full Text] [Related]
22. Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations.
Shono T; Tofilon PJ; Bruner JM; Owolabi O; Lang FF
Cancer Res; 2001 Jun; 61(11):4375-81. PubMed ID: 11389063
[TBL] [Abstract][Full Text] [Related]
23. Oligodendrogliomas in relation to astrocytes differentiation. Clinicopathologic and immunohistochemical study.
Tena-Suck ML; Moreno-Jiménez S; Alonso M; Aguirre-Crux L; Sánchez A
Ann Diagn Pathol; 2008 Oct; 12(5):313-21. PubMed ID: 18774492
[TBL] [Abstract][Full Text] [Related]
24. Differential effects of interferon-gamma on the expression of cyclooxygenase-2 in high-grade human gliomas versus primary astrocytes.
Janabi N; Jensen PN; Major EO
J Neuroimmunol; 2004 Nov; 156(1-2):113-22. PubMed ID: 15465602
[TBL] [Abstract][Full Text] [Related]
25. In vivo expression of cyclooxygenase-2 in rat brain following intraparenchymal injection of bacterial endotoxin and inflammatory cytokines.
Minghetti L; Walsh DT; Levi G; Perry VH
J Neuropathol Exp Neurol; 1999 Nov; 58(11):1184-91. PubMed ID: 10560661
[TBL] [Abstract][Full Text] [Related]
26. Expression of cyclooxygenase-2 and inducible nitric oxide synthase in human ovarian tumors and tumor-associated macrophages.
Klimp AH; Hollema H; Kempinga C; van der Zee AG; de Vries EG; Daemen T
Cancer Res; 2001 Oct; 61(19):7305-9. PubMed ID: 11585770
[TBL] [Abstract][Full Text] [Related]
27. Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398.
Joki T; Heese O; Nikas DC; Bello L; Zhang J; Kraeft SK; Seyfried NT; Abe T; Chen LB; Carroll RS; Black PM
Cancer Res; 2000 Sep; 60(17):4926-31. PubMed ID: 10987308
[TBL] [Abstract][Full Text] [Related]
28. The prognostic significance of DNA topoisomerase II-alpha (Ki-S1), p21/Cip-1, and p27/Kip-1 protein immunoexpression in oligodendrogliomas.
Korshunov A; Golanov A
Arch Pathol Lab Med; 2001 Jul; 125(7):892-8. PubMed ID: 11419973
[TBL] [Abstract][Full Text] [Related]
29. Cellular localization of cyclooxygenase-1 and cyclooxygenase-2 in the normal mouse, rat, and human retina.
Ju WK; Neufeld AH
J Comp Neurol; 2002 Oct; 452(4):392-9. PubMed ID: 12355421
[TBL] [Abstract][Full Text] [Related]
30. Expression of cyclooxygenase-2 and microsomal prostaglandin-E synthase in amoeboid microglial cells in the developing brain and effects of cyclooxygenase-2 neutralization on BV-2 microglial cells.
Li P; Kaur C; Lu J; Sivakumar V; Dheen ST; Ling EA
J Neurosci Res; 2010 May; 88(7):1577-94. PubMed ID: 20025057
[TBL] [Abstract][Full Text] [Related]
31. Cyclooxygenase-1 in human Alzheimer and control brain: quantitative analysis of expression by microglia and CA3 hippocampal neurons.
Yermakova AV; Rollins J; Callahan LM; Rogers J; O'Banion MK
J Neuropathol Exp Neurol; 1999 Nov; 58(11):1135-46. PubMed ID: 10560656
[TBL] [Abstract][Full Text] [Related]
32. Macrophage/microglial cell subpopulations in glioblastoma multiforme relapses are differentially altered by radiochemotherapy.
Deininger MH; Pater S; Strik H; Meyermann R
J Neurooncol; 2001 Dec; 55(3):141-7. PubMed ID: 11859968
[TBL] [Abstract][Full Text] [Related]
33. Expression of cyclooxygenase-2 in astrocytes of human brain after global ischemia.
Maślińska D; Woźniak R; Kaliszek A; Modelska I
Folia Neuropathol; 1999; 37(2):75-9. PubMed ID: 10464424
[TBL] [Abstract][Full Text] [Related]
34. Telomerase expression shows differences across multiple regions of oligodendroglioma versus high grade astrocytomas but shows correlation with Mib-1 labelling.
Kleinschmidt-DeMasters BK; Hashizumi TL; Sze CI; Lillehei KO; Shroyer AL; Shroyer KR
J Clin Pathol; 1998 Apr; 51(4):284-93. PubMed ID: 9659240
[TBL] [Abstract][Full Text] [Related]
35. Nogo-A: a useful marker for the diagnosis of oligodendroglioma and for identifying 1p19q codeletion.
Marucci G; Di Oto E; Farnedi A; Panzacchi R; Ligorio C; Foschini MP
Hum Pathol; 2012 Mar; 43(3):374-80. PubMed ID: 21835431
[TBL] [Abstract][Full Text] [Related]
36. Augmented expression of cyclooxygenase-2 in human atherosclerotic lesions.
Schönbeck U; Sukhova GK; Graber P; Coulter S; Libby P
Am J Pathol; 1999 Oct; 155(4):1281-91. PubMed ID: 10514410
[TBL] [Abstract][Full Text] [Related]
37. Nitric oxide synthase expression of oligodendrogliomas.
Broholm H; Braendstrup O; Lauritzen M
Clin Neuropathol; 2001; 20(6):233-8. PubMed ID: 11758777
[TBL] [Abstract][Full Text] [Related]
38. Cyclooxygenase-2 (COX-2) expression by immunohistochemistry in glioblastoma multiforme.
Prayson RA; Castilla EA; Vogelbaum MA; Barnett GH
Ann Diagn Pathol; 2002 Jun; 6(3):148-53. PubMed ID: 12089724
[TBL] [Abstract][Full Text] [Related]
39. Oligodendroglioma: CD44 as a possible prognostic opportunity.
Buccoliero AM; Caldarella A; Arganini L; Mennonna P; Ammanati F; Taddei A; Taddei GL
Clin Neuropathol; 2003; 22(4):169-75. PubMed ID: 12908752
[TBL] [Abstract][Full Text] [Related]
40. Novel regulation of cyclooxygenase-2 expression and prostaglandin E2 production by IFN-gamma in human macrophages.
Barrios-Rodiles M; Chadee K
J Immunol; 1998 Sep; 161(5):2441-8. PubMed ID: 9725242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
